المؤلفون: S Møller-Bisgaard (3236373), K Hørslev-Petersen (2563924), B Ejbjerg (5623505), ML Hetland (3236385), R Christensen (2566168), LM Ørnbjerg (4391653), D Glinatsi (3236364), JM Møller (3697903), M Boesen (2566153), K Stengaard-Pedersen (3236382), OR Madsen (8144448), B Jensen (8144445), JA Villadsen (11381662), EM Hauge (5796596), P Bennett (7779719), O Hendricks (2563942), K Asmussen (11381665), M Kowalski (7683677), H Lindegaard (3236343), H Bliddal (806194), NS Krogh (3236340), T Ellingsen (3236325), AH Nielsen (11381668), L Larsen (11381671), AG Jurik (2563939), HS Thomsen (11381674), M Østergaard (2563936)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Cancer, modifying antirheumatic drugs, magnetic resonance imaging, intensifying conventional dmards, health assessment questionnaire, conventional synthetic disease, assessed 4 months, 9 – 4, p >< b, nct01656278 , 9 – 3, 03 – 0, clinical disease activity, confidence interval 1, key secondary outcomes, clinical remission ’), initiating biologics compared, 5 )., crp ≤ 3, 0 – 2, mri combined inflammation, based treatment escalations, first biologic compared, clinical remission

Relation: https://figshare.com/articles/dataset/Effect_of_initiating_biologics_compared_to_intensifying_conventional_DMARDs_on_clinical_and_MRI_outcomes_in_established_rheumatoid_arthritis_patients_in_clinical_remission_Secondary_analyses_of_the_IMAGINE-RA_trial/16565476

الاتاحة: https://doi.org/10.6084/m9.figshare.16565476.v1